Study to Evaluate the Efficacy and Safety of REGN3918 in Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH)
Clinical trial NCT03946748 · COMPLETED
Trial details
- NCT number
- NCT03946748
- Sponsor
- Regeneron Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-16
- Primary completion
- 2021-06-09
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.